迅速診断市場規模、シェア、成長分析、製品別、購入先別、技術別、流通チャネル別、最終用途別、地域別 - 産業予測、2025-2032年

迅速診断の世界市場規模は2023年に364億米ドルと評価され、2024年の441億2,000万米ドルから2032年には2,054億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは21.2％で成長する見通しです。

感染症や慢性疾患の世界の急増と精密診断に対する需要の高まりが、迅速診断市場の大幅な成長を牽引する見通しです。革新的な診断技術の研究への継続的な投資は、業界プロバイダーに新たな機会を創出します。ポイントオブケアや在宅検査ソリューションの人気が高まっていることも、この勢いをさらに後押ししています。さらに、早期診断の認知度向上と迅速診断技術の改善を目的とした政府の積極的な取り組みが、2031年まで迅速診断企業の収益を強化すると予想されます。しかし、高度な診断製品に関連する高コスト、熟練した専門家の不足、厳しい規制環境、サプライチェーンの問題などの課題は、調査期間中およびそれ以降を通じて普及の妨げとなる可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

迅速診断市場規模：製品別

• 市場概要
• 感染症検査
  • 呼吸器感染症検査製品
  • インフルエンザ
  • 肝炎
  • HIV
  • その他の感染症検査
• 血糖モニタリング
• 心臓代謝検査
• 凝固検査製品
• 妊娠と生殖能力の検査
• 腫瘍/がんマーカー検査製品
• 尿検査製品
• コレステロール検査製品
• 血液検査製品
• 薬物乱用（DOA）検査製品
• 便潜血検査製品
• その他の製品

迅速診断市場規模：購入先別

• 市場概要
• 店頭
• 処方箋に基づく検査

迅速診断市場規模：技術別

• 市場概要
• フロースルー
• 固相
• ラテラルフロー
• 凝集アッセイ
• その他のテクノロジー

迅速診断市場規模：流通チャネル別

• 市場概要
• 病院薬局
• 店舗
• eコマース
• その他の流通チャネル

迅速診断市場規模：最終用途別

• 市場概要
• 診断センター
• ホームケア
• 病院薬局
• その他のエンドユーザー

迅速診断市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Danaher（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• QuidelOrtho（USA）
• Bio-Rad Laboratories（USA）
• Hologic（USA）
• Cepheid（USA）
• Ortho Clinical Diagnostics（USA）
• Siemens Healthineers（Germany）
• Sysmex（Japan）
• Fujifilm Holdings（Japan）
• DiaSorin（Italy）
• BioMerieux（France）
• Instrumentation Laboratory（USA）

結論と提言

Global Rapid Diagnostics Market size was valued at USD 36.4 billion in 2023 and is poised to grow from USD 44.12 billion in 2024 to USD 205.41 billion by 2032, growing at a CAGR of 21.2% during the forecast period (2025-2032).

The global surge in infectious and chronic diseases, coupled with an increasing demand for precision diagnostics, is poised to drive significant growth in the rapid diagnostics market. Continued investment in researching innovative diagnostic technologies will create new opportunities for industry providers. The rising popularity of point-of-care and home-based testing solutions further supports this momentum. Additionally, proactive government initiatives aimed at enhancing awareness of early diagnosis and improving rapid diagnostic technologies are anticipated to bolster revenue for rapid diagnostics companies through 2031. However, challenges such as the high costs associated with advanced diagnostic products, a shortage of skilled professionals, stringent regulatory environments, and supply chain issues may hinder widespread adoption throughout the study period and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Rapid Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Rapid Diagnostics Market Segments Analysis

Global Rapid Diagnostics Market is segmented by Product, Purchase, Technology, Distribution Channel, End Use and region. Based on Product, the market is segmented into Infectious Disease Testing, Glucose Monitoring, Cardiometabolic Testing, Coagulation Testing Products, Pregnancy And Fertility Testing, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Fecal Occult Testing Products and Other Products. Based on Purchase, the market is segmented into OTC and Prescription-Based Tests. Based on Technology, the market is segmented into Flow-Through, Solid Phase, Lateral Flow, Agglutination Assays and Other Technologies. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Brick & Mortar, E-Commerce and Other Distribution Channels. Based on End Use, the market is segmented into Diagnostic Centers, Homecare Settings, Hospital Pharmacies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is experiencing significant growth driven by the rising prevalence of infectious diseases worldwide. As these diseases become more widespread, there is an increasing demand for effective diagnostic solutions. Rapid testing enables timely detection of infections, allowing for prompt interventions that can prevent the escalation of outbreaks into potential pandemics. This heightened awareness of infectious diseases and the importance of accurate diagnostics is further propelling the demand for rapid diagnostic tools. Consequently, the need for advanced diagnostic procedures is pivotal in addressing health crises and ensuring public safety on a global scale.

Restraints in the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market faces significant constraints due to stringent regulations imposed by authorities and governments, necessitating comprehensive documentation and testing. These rigorous compliance requirements create challenges for companies in the sector, often leading to delays in obtaining necessary approvals for their products. This intricate approval process can hinder innovation and slow the overall growth trajectory of the rapid diagnostics market, potentially affecting its future outlook and limiting timely access to critical diagnostic tools. Consequently, the complex regulatory environment poses a substantial barrier to the advancement and widespread adoption of rapid diagnostics technologies.

Market Trends of the Global Rapid Diagnostics Market

The Global Rapid Diagnostics market is witnessing a significant trend towards the integration of artificial intelligence (AI) technologies, enhancing accuracy and efficiency in diagnostic processes. Companies are increasingly harnessing AI for predictive analytics, enabling early disease detection and improved patient outcomes. This shift is driven by the rapid digitization of healthcare, which facilitates real-time data analysis and personalized medicine approaches. As AI continues to evolve, it will create new opportunities in the rapid diagnostics sector, ultimately optimizing healthcare workflows and fostering innovation. This trend is expected to shape the landscape of diagnostics, paving the way for smarter, faster, and more reliable healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Rapid Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Infectious Disease Testing
  • Respiratory Infection Testing Products
  • Influenza
  • Hepatitis
  • HIV
  • Other Infectious Disease Tests
• Glucose Monitoring
• Cardiometabolic Testing
• Coagulation Testing Products
• Pregnancy And Fertility Testing
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drug-Of-Abuse (DOA) Testing Products
• Fecal Occult Testing Products
• Other Products

Global Rapid Diagnostics Market Size by Purchase & CAGR (2025-2032)

• Market Overview
• OTC
• Prescription-Based Tests

Global Rapid Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Flow-Through
• Solid Phase
• Lateral Flow
• Agglutination Assays
• Other Technologies

Global Rapid Diagnostics Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Brick & Mortar
• E-Commerce
• Other Distribution Channels

Global Rapid Diagnostics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users

Global Rapid Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Purchase, Technology, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Product, Purchase, Technology, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Purchase, Technology, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Purchase, Technology, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Purchase, Technology, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations